Healthcare Losers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Evoke Pharma Inc (NASDAQ:EVOK), Cerulean Pharma Inc (NASDAQ:CERU)

On Friday, Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced that its shareholders had approved 1-for-4 reverse stock split of company common stock. Company shares sank more than 5% in morning trading. The company said that the effective date of the reverse stock split would be disclosed at a future date after The company complies with “standard NYSE administrative processes.” The company stock performance was -9.09% in last … Continue reading Healthcare Losers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Evoke Pharma Inc (NASDAQ:EVOK), Cerulean Pharma Inc (NASDAQ:CERU)

FB Nasdaq FB Facebook

Stocks In News: RetailMeNot Inc (NASDAQ:SALE), Cheniere Energy, Inc. (NYSEMKT:LNG), Yandex NV(NASDAQ:YNDX), Inovio Pharmaceuticals Inc (NYSEMKT:INO)

RetailMeNot Inc (NASDAQ:SALE) SVP Jagjit Bath sold 2,500 shares of the stock on the open market in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $29.75, for a total transaction of $74,375.00. Following the completion of the sale, the senior vice president now directly owns 30,000 shares in the company, valued at approximately $892,500. RetailMeNot Inc (NASDAQ:SALE) stock … Continue reading Stocks In News: RetailMeNot Inc (NASDAQ:SALE), Cheniere Energy, Inc. (NYSEMKT:LNG), Yandex NV(NASDAQ:YNDX), Inovio Pharmaceuticals Inc (NYSEMKT:INO)

Notable Decliners: salesforce.com, inc. (NYSE:CRM), Liquid Holdings Group Inc (NASDAQ:LIQD), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Zogenix, Inc. (NASDAQ:ZGNX)

salesforce.com, inc. (NYSE:CRM), the biggest maker of customer-management software, forecast second-quarter sales that exceeded analysts’ predictions as the company’s Web-based products continue to lure new users. Revenue in the quarter ending in July will be about $1.29 billion, the San Francisco-based company said yesterday in a statement. salesforce.com, inc. (NYSE:CRM) stock performance was -5.10% in last session and finished the day at $50.19. Traded volume … Continue reading Notable Decliners: salesforce.com, inc. (NYSE:CRM), Liquid Holdings Group Inc (NASDAQ:LIQD), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Zogenix, Inc. (NASDAQ:ZGNX)

Bearish Stocks: Inovio Pharmaceuticals Inc (NYSEMKT:INO), BroadSoft Inc (NASDAQ:BSFT), KBR (NYSE:KBR), Ballard Power Systems (NASDAQ:BLDP)

Inovio Pharmaceuticals (NYSE:INO)’s shares were the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 28,830,223 shares, a decline of 2.1% from the March 31st total of 28,233,502 shares, Analyst Ratings News reports.Inovio Pharmaceuticals Inc (NYSEMKT:INO)stock performance was -6.25% in last session and finished the day at $ 2.40. Traded volume was 5.94 million shares … Continue reading Bearish Stocks: Inovio Pharmaceuticals Inc (NYSEMKT:INO), BroadSoft Inc (NASDAQ:BSFT), KBR (NYSE:KBR), Ballard Power Systems (NASDAQ:BLDP)

Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day at $2.60. Traded volume was 16.17million shares in the last … Continue reading Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Small CAp Active Runners: Inovio Pharmaceuticals (NYSEMKT:INO), Walter Energy (NYSE:WLT), EXACT Sciences Corporation (NASDAQ:EXAS), Western Asset Mortgage Capital (NYSE:WMC)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced the appointment of E.J. Brandreth as vice president of quality. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -5.71% in last session and finished the day at $3.14. Traded volume was 9.33million shares in the last session and the average volume of the stock remained 7.54million shares. The beta of the stock remained 3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) insider ownership is … Continue reading Small CAp Active Runners: Inovio Pharmaceuticals (NYSEMKT:INO), Walter Energy (NYSE:WLT), EXACT Sciences Corporation (NASDAQ:EXAS), Western Asset Mortgage Capital (NYSE:WMC)